CNBC: Eli Lilly looking for smaller acquisitions: CEO

 

The big large-scale combinations are not right for Lilly right now, says John Lechleiter, Eli Lilly CEO, discussing how the company plans to expand its pharmaceutical footprint through acquiring smaller companies. Also Lechleiter weighs in on growing its animal health care business.